On the recordMarch 30, 2023
The problem is that the person negotiating on behalf of the patient should not be getting paid by the other side.
Source
congress.govEditor's note · Context
Wyden highlights a conflict of interest in drug price negotiations.
Share & report
More from Ron Wyden
Oct 29, 2025
Our country’s technology advantage is not worth giving away just so Trump can get a few headlines.
Jun 26, 2025
Are you for caviar or kids? Mar-a-Lago or the middle class? Hedge funds or healthcare? I know what side you're on—now we have got to make sure that a whole lot of Senate Republicans make the right choice too.
Other voices in this conversation
